1. Home
  2. RMBI vs KROS Comparison

RMBI vs KROS Comparison

Compare RMBI & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richmond Mutual Bancorporation Inc.

RMBI

Richmond Mutual Bancorporation Inc.

HOLD

Current Price

$16.03

Market Cap

248.0M

Sector

Finance

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$10.85

Market Cap

206.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMBI
KROS
Founded
1887
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
248.0M
206.0M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
RMBI
KROS
Price
$16.03
$10.85
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$21.86
AVG Volume (30 Days)
42.6K
181.7K
Earning Date
04-23-2026
05-06-2026
Dividend Yield
3.85%
N/A
EPS Growth
27.17
146.00
EPS
0.28
N/A
Revenue
N/A
$243,864,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2,751.79
P/E Ratio
$57.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.77
$9.69
52 Week High
$16.59
$22.55

Technical Indicators

Market Signals
Indicator
RMBI
KROS
Relative Strength Index (RSI) 62.40 53.76
Support Level $13.05 $10.57
Resistance Level $16.13 $11.55
Average True Range (ATR) 0.30 0.52
MACD 0.02 0.11
Stochastic Oscillator 77.55 68.97

Price Performance

Historical Comparison
RMBI
KROS

About RMBI Richmond Mutual Bancorporation Inc.

Richmond Mutual Bancorp Inc is a bank holding company. Along with its subsidiary, it is mainly engaged in attracting deposits from the general public, as well as brokered deposits, and investing those funds in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one- to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. It also obtains funds by utilizing Federal Home Loan Bank (FHLB) advances. These funds are generally invested in investment securities, including mortgage-backed and mortgage-related securities and agency and municipal bonds. The Group's primary market area includes Wayne and Shelby counties in Indiana and Shelby, Miami, and Franklin counties in Ohio.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: